RecruitingNCT05565209

Left Atrial Appendage Closure Registry of Henri Mondor Hospital


Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

250 participants

Start Date

Sep 24, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Intro: Patients with atrial fibrillation are at significant risk of thrombus formation in the left atrial appendage, which can lead to strokes or systemic embolisms. This risk justifies first-line prescribing of long-term oral anticoagulant therapy in these patients. Percutaneous left atrial appendage closure, is an interventional cardiology technique for patients at high risk of stroke related to atrial fibrillation in whom long term anticoagulation therapy cannot be conducted. This procedure involves implantation of an occlusion device into the left atrial appendage to close it and prevent migration of thrombotic material that could otherwise cause distant embolism. Closure of the left atrial appendage avoids long-term prescription of anticoagulants while protecting patients against the risk of systemic embolism and stroke. Hypothesis/Objective: the main objective of this study is to assess the long term efficacy of left atrial closure, 5 years after the procedure Method: 150 patients will be included prospectively. We will also include restropectively100 other patients, previously treated by left atrial appendage closure at Henri Mondor hospital. Demographic, clinical, echocardiographic, and computed tomography data will be obtained by physical examination or medical records. Conclusion: this study will allow to assess the long term efficacy of left atrial closure in atrial fibrillation patients.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a registry study at Henri Mondor Hospital in France tracking all patients who undergo a procedure to close the left atrial appendage (LAA) — a small pouch in the heart that is a common source of blood clots in people with atrial fibrillation. The registry collects information on outcomes regardless of whether the procedure was successful. **You may be eligible if...** - Your doctor has recommended LAA closure with an implantable device - You are willing to participate in the registry - You are an adult (18 or older) - You are covered by French social security **You may NOT be eligible if...** - You refuse to participate - You are a minor (under 18) - You are not enrolled in the French social security system Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSA brief descriptive name used to refer to the intervention(s) studied

Details that can be made public about the intervention


Locations(1)

Assistance Publique Hôpitaux de Paris - CHU HENRI MONDOR

Créteil, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05565209


Related Trials